It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Quote from source:
American authorities guarantee that the GlaxoSmithKline knew that the Avandia could provoke heart attacks
by Sara Sanz Pinto
BREAKING NEWS
Avandia, a drug often prescribed to patients with diabetes, may have caused millions of heart attacks around the world. This is the conclusion of a 334-page report submitted by the U.S. Senate on Saturday. According to the American authorities, the GlaxoSmith-Kline (GSK), pharmaceutical company that produces the drug, knew the risks to which patients were exposed, but always kept them hidden from the public. "GSK executives tried to intimidate independent researchers, using strategies to minimize or hide the findings that Avandia could increase cardiovascular risks and hid studies that were developing competing drugs with reduced risk," says the report.
"Americans have a right to know that there are serious health risks associated with Avandia and GlaxoSmithKline had a responsibility to tell them," said Democrat Max Baucus, U.S. Senator and chairman of the committee that conducted the study. "Patients rely on pharmaceutical companies for health and life, and GSK had abused that trust," he added. The report is also signed by Sen. Chuck Grasseley, leader of the Republicans on the committee that wants to withdraw the drug from the market.
The drugmaker denies all charges. "No study shows a statistically relevant correlation between Avandia and ischemic heart disease [disease that leads to narrowing of the coronary arteries] or myocardial infarction," stated the spokesman of the company, Nancy Pekarek, to CNN. "The Food and Drug Administration (FDA) has revised the information and concluded that the drug should be in the market."